Clinical Features	Time to Death		AGE		NEOPLASM.DISEASESTAGE		PATHOLOGY.T.STAGE		PATHOLOGY.N.STAGE		PATHOLOGY.M.STAGE		GENDER		KARNOFSKY.PERFORMANCE.SCORE	
	nMutated (%)	nWild-Type	logrank test_P	logrank test_Q	t-test_P	t-test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	Fisher's exact test_P	Fisher's exact test_Q	t-test_P	t-test_Q
CDC27	4 (4%)	105	0.58646	1	0.7761	1	0.36359	1	0.77358	1	NA	NA	0.074587	1	0.58732	1	NA	NA
IL32	4 (4%)	105	0.10484	1	0.35238	1	0.57802	1	0.77358	1	NA	NA	0.21379	1	0.30749	1	NA	NA
NF2	7 (6%)	102	0.75479	1	0.29801	1	0.12343	1	0.37227	1	0.047233	1	0.035696	0.821	1	1	NA	NA
PPARGC1B	3 (3%)	106	0.74688	1	0.3941	1	NA	NA	0.35058	1	NA	NA	NA	NA	1	1	NA	NA